Minimal residual disease in solid tumor malignancies: A review

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 1, 1998, Pages 9-18

  Ross, Amy A ^a  

^a Cell Pro Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CELL VIABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASM, RESIDUAL; NEUROBLASTOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031948936     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.9     Document Type: Review

References (49)

1. Brenner, M.K., Rill, D.R., Moen, R.C., et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993.
2. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994.
3. Rill, D.R., Santana, V.M., Roberts, W.M., et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
4. Moss, T.J., Reynolds, C.P., Sather, H.N., et al. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N. Engl. J. Med. 324:219, 1991.
5. Sharp, J.G., Kessinger, A., Vaughan, W.P., et al. Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int. J. Cell Cloning 10 (Suppl. 1):92, 1992.
6. Shpall, E.J., Gee, A.P., Hogan, C., et al. Bone marrow metastases. Hematol. Oncol. Clin. North Am. 10:321, 1996.
7. Fields, K.K., Elfenbein, G.J., Trudeau, W.L., et al. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J. Clin. Oncol. 14:1868, 1996.
8. Pedrazzoli, P., Battaglia, M., Da Prada, G.A., et al. Role of tumor cells contaminating the graft in breast cancer recurrence after high-dose chemotherapy. Bone Marrow Transplant. 20:167, 1997.
9. Vredenburgh, J.J., Silva, O., Broadwater, G., et al. The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support. Biol. Blood Marrow Transplant. 3:91, 1997.
10. Salsbury, A.J. The significance of the circulating cancer cell. Cancer Treat. Rev. 2:55, 1975.
11. Moss, T.J. & Ross, A.A. Detection of tumor cells in the peripheral blood of patients with solid tumor malignancies. J. Hematother. 1:225, 1992.
12. Datta, Y.H., Adams, P.T., Drobyski, W.R., et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol. 12:475, 1994.
13. Neumaier, M., Gerhard, M. & Wagener, C. Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159:43, 1995.
14. Pelkey, T.J., Frierson, Jr., H.F. & Bruns, D.E. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin. Chem. 42:1369, 1996.
15. Schoenfeld, A., Kruger, K.H., Gomm, J., et al. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur. J. Cancer 33A:854, 1997.
16. Wolin, M.J., Ross, A.A., Rigor, R.L., et al. Are single apheresis collections of blood stem cells less likely to contain cancer cells than multiple collections? Blood 86 (Suppl. 1):235a (abstract), 1995.
17. Chaiwun, B., Saad, A.D., Groshen, S., et al. Immunohistochemical detection of occult carcinoma in bone marrow and blood. Diagn. Oncol., 2:267, 1992.
18. Pantel, K. & Riethmüller, G. Methods for detection of micrometastatic carcinoma cells in bone marrow, blood and lymph nodes. Onkologie 18:394, 1995.
19. Müller, P., Weckermann, D., Riethmüller, G., et al. Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 88:8, 1996.
20. Berger, U., Mansi, J.L., Wilson, P., et al. Detection of estrogen receptor in bone marrow from patients with breast cancer. J. Clin. Oncol. 5:1779, 1987.
21. Pantel, K., Schlimok, G., Angstwurm, M., et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 3:165, 1994.
22. Emerman, J.T., Stingl, J., Petersen, A., et al. Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells. Breast Cancer Res. Treat. 41:147, 1996.
23. Ross, A.A., Cooper, B.W., Lazarus, H.M., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 9:2605, 1993.
24. Passos-Coelho, J., Ross, A.A., Davis, J.M., et al. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroperoxycyclophosphamide. Cancer Res. 54:2366, 1994.
25. Passos-Coelho, J.L., Ross, A.A., Moss, T.J., et al. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 85:1138, 1995.
26. Passos-Coelho, J.L., Ross, A.A., Kahn, D.J., et al. Similar breast cancer cell contamination of single-day peripheralblood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J. Clin. Oncol. 14:2569, 1996.
27. Miyajima, Y., Horibe, K., Fukuda, M., et al. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer 77:1214, 1996.
28. Berois, N., Varangot, M., Osinaga, E., et al. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res. 17:2639, 1997.
29. Mapara, M.Y., Körner, I.J., Hildebrandt, M., et al. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89:337, 1997.
30. Zippelius, A., Kufer, P., Honold, G., et al. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J. Clin. Oncol. 15:2701, 1997.
31. Noguchi, S., Motomura, K., Inaji, H., et al. Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res. 52:6594, 1992.
32. Moss, T.J., Sanders, D.G., Lasky, L.C., et al. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76:1879, 1990.
33. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
34. Ross, A.A., Layton, T.J., Ostrander, A.B., et al. Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts. J. Hematother. 5:549, 1996.
35. Gluck, S., Ross, A.A., Goldstein, L., et al. Detection of breast cancer cells in the apheresis product and their potential clinical significance. Blood 88 (Suppl.1):605a (abstract), 1996.
36. Schulze, R., Schulze, M., Wischnik, A., et al. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant. 19:1223, 1997.
37. Mann, S.L., Joshi, S.S., Crouse, D.A., et al. Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells. Breast Cancer Res. Treat. 44:115, 1997.
38. Franklin, W.A., Shpall, E.J., Archer, P., et al. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res. Treat. 41:1, 1996.
39. Nagai, J., Kigasawa, H., Tomioka, K., et al. Immunocytochemical detection of bone marrow-invasive neuroblastoma cells. Eur. J. Haematol. 53:74, 1994.
40. Moss, T.J., Cairo, M., Santana, V.M., et al. Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood 83:3085, 1994.
41. Cain, J.M., Ellis, G.K., Collins, C., et al. Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment. Gynecol. Oncol. 38:442, 1990.
42. Ross, A.A., Miller, G.W., Moss, T.J., et al. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer. Bone Marrow Transplant. 15:929, 1995.
43. Shpall, E.J., Jones, R.B., Bast, R.C. Jr., et al. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial. J. Clin. Oncol. 9:85, 1991.
44. Shpall, E.J., Jones, R.B., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
45. Handgretinger, R., Greil, J., Schürmann, U., et al. Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma. J. Hematother. 6:235, 1997.
46. Hohaus, S., Pförsich, M., Murea, S., et al. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer. Br. J. Haematol. 97:881, 1997.
47. Ybanez, J., Lazarus, H., Ross, A., et al. Impact of occult tumor reinfusion on outcome after high-dose chemotherapy in patients with advanced breast cancer. Blood 86 (Suppl. 1):386a (abstract), 1995.
48. Brockstein, B.E., Ross, A.A., Moss, T.J., et al. Tumor cell contamination of bone marrow harvests products: Clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapy. J. Hematother. 5:605, 1996.
49. Moss, T.J., Cooper, B., Kennedy, M.J., et al. The prognostic value of immunocytochemical (ICC) analysis on bone marrow (BM) and stem cell products (PBSC) taken from patients with stage IV breast cancer undergoing autologous transplant (ABMT) therapy. Proc. Am. Soc. Clin. Oncol. 16:90a (abstract), 1997.